KDR and neoplasm: By neutralizing VEGF and preventing the activation of VEGF tyrosine kinase receptors VEGFR1 and VEGFR2 on endothelial cells, it attenuates VEGFA-dependent tumor blood vessel formation, promotes tumor vascular normalization and promotes tumor cell apoptosis (1) (Figure 1).